SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,790.00    95.00 (1.42%)
Bid:
6,790.00
Ask:
6,795.00
Spread: 5.00 (0.074%)
Market Cap: £5.01b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

8 Nov 2010 07:00

RNS Number : 7397V
Spirax-Sarco Engineering PLC
08 November 2010
 



 

Spirax-Sarco Engineering plc

 

Charlton House

Cheltenham

Glos. GL53 8ER

 

 

News Release

 

 

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

 

 

Monday 8th November 2010

INTERIM MANAGEMENT STATEMENT

 

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period since 30th June 2010.

 

Trading

Sales growth thus far in the second half has improved from the first half year. Sales for the ten months through October 2010 were ahead 14%, including an organic sales increase of 9%, with 5% contributed equally between acquisitions and favourable currency movements. Sterling has been relatively stable over recent months and at current exchange rates, we would expect to see a similar percentage currency gain for the full year.

Since the half year, sales in the steam business increased strongly in Asia Pacific as several large projects were shipped in Korea. In the Americas, organic sales growth was in line with the first half due to a stronger performance in South America offset by some weakening in North America. Following a flat first half year, we saw moderate sales growth in EMEA led by strong performances from Germany and Russia. Watson-Marlow, our peristaltic pump business, continued its robust sales growth.

 

Adjusted operating profit continues to benefit from good operational gearing, the cost reductions implemented last year and favourable currency movements. In the period, we continued to invest in our global manufacturing strategy, add sales resources in developing markets and increase R&D investments, all aimed at enhancing our future growth and margin prospects.

 

Financial position

We operate with a strong balance sheet and the Group had a net cash balance of £30 million at 31st October 2010. There has been no material change in the financial position of the Group during the period.

 

Outlook

Global economic activity and industrial output have shown positive growth this year, although more recently the rates of growth have been broadly slowing and we remain alert to any significant slowdown. Sales growth returned in the last two months of 2009 and the easier comparisons are therefore now behind us. However, we expect to make good progress in 2010 and, as we reported at the half-year, to see a more normal second-half bias of sales and profits.

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 4,500 people, of whom over 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBCSGBGGU
Date   Source Headline
8th Apr 20259:34 amRNSDirector/PDMR Shareholding
8th Apr 20259:32 amRNSNotice of AGM
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
19th Mar 202511:43 amRNSHolding(s) in Company
12th Mar 20257:00 amRNSDividend Declaration
11th Mar 20257:00 amRNS2024 Full Year Results
10th Mar 20251:42 pmRNSDirector/PDMR Shareholding
10th Feb 20252:23 pmRNSDirector/PDMR Shareholding
31st Jan 20259:00 amRNSBoard Appointment
14th Jan 20253:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSBoard Chair Succession
11th Dec 20241:53 pmRNSDirector/PDMR Shareholding
27th Nov 20244:18 pmRNSDirector/PDMR Shareholding
15th Nov 20241:19 pmRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSTrading Update
16th Oct 20248:48 amRNSHolding(s) in Company
11th Oct 20241:50 pmRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSDirector/PDMR Shareholding
10th Oct 20243:29 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSCapital Markets Event
18th Sep 20249:47 amRNSHolding(s) in Company
16th Sep 202410:12 amRNSHolding(s) in Company
13th Sep 202410:57 amRNSHolding(s) in Company
12th Aug 202410:44 amRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNS2024 Half Year Results
1st Jul 20247:05 amRNSConfirmation of CFO Start Date
5th Jun 20243:46 pmRNSChange of Name
29th May 20248:45 amRNSBoard Succession
15th May 20244:56 pmRNSResult of AGM
15th May 20247:00 amRNSAGM Trading Statement
10th Apr 20244:44 pmRNSDirector/PDMR Shareholding
26th Mar 20249:33 amRNSDirector/PDMR Shareholding
20th Mar 202410:00 amRNSDirector/PDMR Shareholding
18th Mar 20242:34 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNS2023 Full Year Results
22nd Feb 20247:00 amRNSSpirax-Sarco Engineering rebrands as Spirax Group
1st Feb 20243:38 pmRNSChange of Director Details
30th Jan 202411:15 amRNSFuture Board Change
17th Jan 20247:00 amRNSLeadership Succession
18th Dec 20237:00 amRNSChief Financial Officer Appointment
21st Nov 20239:15 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSShare Purchases
16th Nov 20237:00 amRNSTrading Update
11th Oct 20238:40 amRNSDirector/PDMR Shareholding
25th Aug 20239:30 amRNSHolding(s) in Company
25th Aug 20238:30 amRNSHolding(s) in Company
10th Aug 20237:00 amRNS2023 Half Year Results
8th Aug 20237:00 amRNSGroup Chief Executive Succession

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.